1. Enf er medades
Causadas por
pr i ones
Franco Romero Cinthya Guadalupe
Romero Cordero Viridiana

2. ¿Qué es un prion?

4. Pr i ones y Pr pc

7. Pr pc y Pr PSc

12. ¿Cómo l as Pr Psc at acan al
cer ebr o?

15. D er i or o
et

16. Infección en ani m es y hum
al anos

18. Enf er m edades
causadas por
pr i ones

19. Kur u

21. C eut zf el dt -Jakob
r

23. I nsom oni
f am l i ar
i
f at al

24. Bibliografía
Patrick R. Murray, Ken S. Rosenthal y Michael A. Pfaller. Microbiología médica. 6ª ed.
ELSEVIER, 2011, p.661.
Martinez, C. (2006, septiembre). Fisiopatología de las enfermedades por priones.
México: Gaceta Medica.
Ryan R, Hill S, Lowe D, Allen K, Taylor M, Mead C. Notification and support for people
exposed to the risk of Creutzfeldt‐Jakob disease (CJD) (or other prion diseases)
through medical treatment (iatrogenically). Cochrane Database of Systematic Reviews
2011, Issue 3. Art. No.: CD007578. DOI: 10.1002/14651858.CD007578.pub2.
Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic
interventions in human prion disease. Neurology 2008; 70(15): 1272-1281.
Prion disease blood test using immunoprecipitation and improved quaking-induced
conversion. Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories,
National Institute of Allergy and Infectious Diseases, National Institutes of Health,
Hamilton, Montana, USA. MEDLINE. Mayo 2011. PMID: 21558432
Prusiner Stanley. Prions. Gran Bretaña. Vol. 95 No. 23. 2009.
Belay E. “Transmissible Spongiform Encelophalopathies in Humans”.Atlanta, Georgia,
UnitedStates. Annue. Rev. Microbiol. 2011.53:283-214.2001.
Belay. E. “ The Public Healt Impact of Pion Diseases”. Atlanta, Georgia, United States.
Annu. Rev. Public Health. 2005.26.191-212. 2005